Abstract
Purpose of Review
The purpose of this review is to provide an overview of dietary phosphorus, its sources, recommended intakes, and its absorption and metabolism in health and in chronic kidney disease and to discuss recent findings in this area with a focus on the effects of inorganic phosphate additives in bone health.
Recent Findings
Recent findings show that increasing dietary phosphorus through inorganic phosphate additives has detrimental effects on bone and mineral metabolism in humans and animals. There is new data supporting an educational intervention to limit phosphate additives in patients with chronic kidney disease to control serum phosphate.
Summary
The average intake of phosphorus in the USA is well above the recommended dietary allowance. Inorganic phosphate additives, which are absorbed at a high rate, account for a substantial and likely underestimated portion of this excessive intake. These additives have negative effects on bone metabolism and present a prime opportunity to lower total phosphorus intake in the USA. Further evidence is needed to confirm whether lowering dietary phosphorus intake would have beneficial effects to improve fracture risk.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Institute of Medicine. DRI: dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: National Academy Press; 1997.
Aloia JF, Vaswani A, Yeh JK, Ellis K, Cohn SH. Total body phosphorus in postmenopausal women. Miner Electrolyte Metab. 1984;10(2):73–6.
Imel EA, Peacock M. X-linked hypophosphatemia: understanding and managment. Drugs Future. 2010;35(9):755–63.
Calvo MS, Moshfegh AJ, Tucker KL. Assessing the health impact of phosphorus in the food supply: issues and considerations. Adv Nutr. 2014;5(1):104–13.
• McClure ST, Chang AR, Selvin E, Rebholz CM, Appel LJ. Dietary sources of phosphorus among adults in the United States: results from NHANES 2001-2014. Nutrients. 2017;9(2):95. Recent NHANES analysis of relative contributions of various dietary sources of phosphorus to total phosphorus intake in the U.S.
Calvo MS, Park YK. Changing phosphorus content of the U.S. diet: potential for adverse effects on bone. J Nutr. 1996;126(4 Suppl):1168S–80S.
Calvo MS, Tucker KL. Is phosphorus intake that exceeds dietary requirements a risk factor in bone health? Ann N Y Acad Sci. 2013;1301:29–35.
Tucker KL, Morita K, Qiao N, Hannan MT, Cupples LA, Kiel DP. Colas, but not other carbonated beverages, are associated with low bone mineral density in older women: the Framingham osteoporosis study. Am J Clin Nutr. 2006;84(4):936–42.
Amato D, Maravilla A, Montoya C, Gaja O, Revilla C, Guerra R, et al. Acute effects of soft drink intake on calcium and phosphate metabolism in immature and adult rats. Rev Investig Clin. 1998;50(3):185–9.
Garcia-Contreras F, Paniagua R, Avila-Diaz M, Cabrera-Munoz L, Martinez-Muniz I, Foyo-Niembro E, et al. Cola beverage consumption induces bone mineralization reduction in ovariectomized rats. Arch Med Res. 2000;31(4):360–5.
Kim SH, Morton DJ, Barrett-Connor EL. Carbonated beverage consumption and bone mineral density among older women: the Rancho Bernardo study. Am J Public Health. 1997;87(2):276–9.
Kristensen M, Jensen M, Kudsk J, Henriksen M, Molgaard C. Short-term effects on bone turnover of replacing milk with cola beverages: a 10-day interventional study in young men. Osteoporos Int. 2005;16(12):1803–8.
Wyshak G. Teenaged girls, carbonated beverage consumption, and bone fractures. Arch Pediatr Adolesc Med. 2000;154(6):610–3.
Wyshak G, Frisch RE. Carbonated beverages, dietary calcium, the dietary calcium/phosphorus ratio, and bone fractures in girls and boys. J Adolesc Health. 1994;15(3):210–5.
Hill Gallant KM. Studying dietary phosphorus intake: the challenge of when a gram is not a gram. Am J Clin Nutr. 2015;102(2):237–8.
•• Scanni R, von Rotz M, Jehle S, Hulter HN, Krapf R. The human response to acute enteral and parenteral phosphate loads. J Am Soc Nephrol. 2014;25(12):2730–9. This study used nasoduodenal and intravenous infusions of phosphate and urine phosphorus recovery to show that the kidney completely compensates for added phosphate loads by increasing phosphaturia, and that there appears to be no role for the intestine in regulating renal phosphate excretion in response to a phosphate load.
• St-Jules DE, Jagannathan R, Gutekunst L, Kalantar-Zadeh K, Sevick MA. Examining the proportion of dietary phosphorus from plants, animals, and food additives excreted in urine. J Ren Nutr. 2017;27(2):78–83. A recent review article aimed at describing the bioavailablity of phosphorus from plant, animal, and inorganic phosphate additive sources. The authors examine the proportion of dietary phosphorus consumed in four controlled feeding studies that is excreted in the urine as an indirect measure of intestinal phosphorus absorption. This paper illustrates clearly that there is a difference between “digestibility” (i.e. bioaccessibility) of phosphorus from various sources that has been shown through in vitro digestion studies, and the actual bioavailability (absorption) of phosphorus from these foods.
Bergwitz C, Juppner H. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med. 2010;61:91–104.
Kido S, Kaneko I, Tatsumi S, Segawa H, Miyamoto K. Vitamin D and type II sodium-dependent phosphate cotransporters. Contrib Nephrol. 2013;180:86–97.
Forster IC, Hernando N, Biber J, Murer H. Phosphate transporters of the SLC20 and SLC34 families. Mol Asp Med. 2013;34(2–3):386–95.
Fleet JC, Peacock M. Physiology of vitamin D, calcium, and phosphate absorption. In: Morris HA, Anderson PH, Nordin BEC, editors. The physiological basis of metabolic bone disease. Boca Raton: CRC Press; 2014. p. 13–40.
Miyamoto K, Ito M, Kuwahata M, Kato S, Segawa H. Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23. Ther Apher Dial. 2005;9(4):331–5.
Yoshida T, Yoshida N, Monkawa T, Hayashi M, Saruta T. Dietary phosphorus deprivation induces 25-hydroxyvitamin D(3) 1alpha-hydroxylase gene expression. Endocrinology. 2001;142(5):1720–6.
Capuano P, Radanovic T, Wagner CA, Bacic D, Kato S, Uchiyama Y, et al. Intestinal and renal adaptation to a low-Pi diet of type II NaPi cotransporters in vitamin D receptor- and 1alphaOHase-deficient mice. Am J Physiol Cell Physiol. 2005;288:C429–C34.
Segawa H, Kaneko I, Yamanaka S, Ito M, Kuwahata M, Inoue Y, et al. Intestinal Na-P(i) cotransporter adaptation to dietary P(i) content in vitamin D receptor null mice. Am J Physiol-Renal. 2004;287(1):F39–47.
Bonjour JP, Caverzasio J. Phosphate transport in the kidney. Rev Physiol Biochem Pharmacol. 1984;100:161–214.
Berndt T, Kumar R. Novel mechanisms in the regulation of phosphorus homeostasis. Physiology (Bethesda). 2009;24:17–25.
Shah B, Krishnarao G, Draper H. The relationship of Ca and P nutrition during adult life and osteoporosis in aged mice. J Nutr. 1967;92:30–42.
Anderson G, Draper H. Effect of dietary phosphorus on calcium metabolism in intact and parathyroidectomized adult rats. J Nutr. 1972;102(9):1123–32.
Draper H, Sie T-L, Bergan J. Osteoporosis in aging rats induced by high phosphorus diets. J Nutr. 1972;102(9):1133–41.
Krishnarao G, Draper H. Influence of dietary phosphate on bone resorption in senescent mice. J Nutr. 1972;102(9):1143–5.
Koyama Y, Rittling SR, Tsuji K, Hino K, Salincarnboriboon R, Yano T, et al. Osteopontin deficiency suppresses high phosphate load-induced bone loss via specific modulation of osteoclasts. Endocrinology. 2006;147(6):3040–9.
Huttunen MM, Tillman I, Viljakainen HT, Tuukkanen J, Peng Z, Pekkinen M, et al. High dietary phosphate intake reduces bone strength in the growing rat skeleton. J Bone Miner Res. 2007;22(1):83–92.
Reiss E, Canterbury JM, Bercovitz MA, Kaplan EL. The role of phosphate in the secretion of parathyroid hormone in man. J Clin Invest. 1970;49(11):2146–9.
Bell RR, Draper HH, Tzeng DY, Shin HK, Schmidt GR. Physiological responses of human adults to foods containing phosphate additives. J Nutr. 1977;107(1):42–50.
Zemel MB, Linkswiler HM. Calcium metabolism in the young adult male as affected by level and form of phosphorus intake and level of calcium intake. J Nutr. 1981;111(2):315–24.
Kuntz D, Marie P, Berhel M, Caulin F. Treatment of post-menopausal osteoporosis with phosphate and intermittent calcitonin. Int J Clin Pharmacol Res. 1986;6(2):157–62.
Silverberg SJ, Shane E, Clemens TL, Dempster DW, Segre GV, Lindsay R, et al. The effect of oral phosphate administration on major indices of skeletal metabolism in normal subjects. J Bone Mineral Res. 1986;1(4):383–8.
Calvo MS, Kumar R, Heath H III. Elevated secretion and action of serum parathyroid hormone in young adults consuming high phosphorus, low calcium diets assembled from common foods. J Clin Endocrinol Metab. 1988;66(4):823–9.
Calvo MS, Heath H III. Acute effects of oral phosphate-salt ingestion on serum phosphorus, serum ionized calcium, and parathyroid hormone in young adults. Am J Clin Nutr. 1988;47(6):1025–9.
Calvo MS, Kumar R, HEATH III H. Persistently elevated parathyroid hormone secretion and action in young women after four weeks of ingesting high phosphorus, low calcium diets. J Clin Endocrinol Metab. 1990;70(5):1334–40.
Brixen K, Nielsen HK, Charles P, Mosekilde L. Effects of a short course of oral phosphate treatment on serum parathyroid hormone (1–84) and biochemical markers of bone turnover: a dose-response study. Calcified Tissue Int. 1992;51(4):276–81.
Kärkkäinen M, Lamberg-Allardt C. An acute intake of phosphate increases parathyroid hormone secretion and inhibits bone formation in young women. J Bone Miner Res. 1996;11(12):1905–12.
Whybro A, Jagger H, Barker M, Eastell R. Phosphate supplementation in young men: lack of effect on calcium homeostasis and bone turnover. Eu J Clin Nutr. 1998;52(1):29–33.
Grimm M, Muller A, Hein G, Funfstuck R, Jahreis G. High phosphorus intake only slightly affects serum minerals, urinary pyridinium crosslinks and renal function in young women. Eur J Clin Nutr. 2001;55(3):153.
Ferrari SL, Bonjour JP, Rizzoli R. Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab. 2005;90(3):1519–24.
Burnett SM, Gunawardene SC, Bringhurst FR, Juppner H, Lee H, Finkelstein JS. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res. 2006;21(8):1187–96.
Antoniucci DM, Yamashita T, Portale AA. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab. 2006;91(8):3144–9.
Kemi VE, Kärkkäinen MU, Lamberg-Allardt CJ. High phosphorus intakes acutely and negatively affect Ca and bone metabolism in a dose-dependent manner in healthy young females. Br J Nutr. 2006;96(03):545–52.
Karp HJ, Vaihia KP, Karkkainen MU, Niemisto MJ, Lamberg-Allardt CJ. Acute effects of different phosphorus sources on calcium and bone metabolism in young women: a whole-foods approach. Calcified Tissue Int. 2007;80(4):251–8.
Kemi VE, Karkkainen MU, Karp HJ, Laitinen KA, Lamberg-Allardt CJ. Increased calcium intake does not completely counteract the effects of increased phosphorus intake on bone: an acute dose-response study in healthy females. Br J Nutr. 2008;99(4):832–9.
Vervloet MG, van Ittersum FJ, Buttler RM, Heijboer AC, Blankenstein MA, ter Wee PM. Effects of dietary phosphate and calcium intake on fibroblast growth factor-23. Clin J Am Soc Nephrol. 2011;6(2):383–9.
Sigrist M, Tang M, Beaulieu M, Espino-Hernandez G, Er L, Djurdjev O, et al. Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial. Nephrol Dial Transplant. 2013;28(1):161–9.
•• Gutiérrez OM, Luzuriaga-McPherson A, Lin Y, Gilbert LC, Ha S-W, Beck GR Jr. Impact of phosphorus-based food additives on bone and mineral metabolism. J Clin Endocrinol Metab. 2015;100(11):4264–71. This is a controlled feeding study that shows the adverse effects of increasing dietary phosphorus through addition of inorganic phosphate additives on bone metabolism in healthy adults. The authors also present complementary studies in mice that show similar adverse effects on bone and mineral metabolism, including detrimental effects of phosphate additives on bone mineral density and cortical and cancellous bone geometry.
Lee AW, Cho SS. Association between phosphorus intake and bone health in the NHANES population. Nutr J. 2015;14(1):28.
Lee K-J, Kim K-S, Kim H-N, Seo J-A, Song S-W. Association between dietary calcium and phosphorus intakes, dietary calcium/phosphorus ratio and bone mass in the Korean population. Nutr J. 2014;13(1):114.
Brot C, Jørgensen N, Madsen O, Jensen L, Sørensen O. Relationships between bone mineral density, serum vitamin D metabolites and calcium: phosphorus intake in healthy perimenopausal women. J Intern Med. 1999;245(5):509–16.
Pinheiro MM, Schuch NJ, Genaro PS, Ciconelli RM, Ferraz MB, Martini LA. Nutrient intakes related to osteoporotic fractures in men and women—the Brazilian osteoporosis study (BRAZOS). Nutr J. 2009;8(1):6.
•• Campos-Obando N, Koek WN, Hooker ER, van der Eerden BC, Pols HA, Hofman A, et al. Serum phosphate is associated with fracture risk: the Rotterdam study and MrOS. J Bone Miner Res. 2017;32(6):1182–93. Serum phosphate levels within the normal range are associated with an increased fracture risk in men and women from the Rotterdam Study and men from MrOS. This was independent of phosphorus intake, but the authors note that phosphate intake accuracy may be limited by assessment methods.
Katsumata S, Matsuzaki H, Katsumata-Tsuboi R, Uehara M, Suzuki K. Effects of high phosphorus diet on bone metabolism-related gene expression in young and aged mice. J Nutr Metab. 2014;2014:575932.
Katsumata S, Matsuzaki H, Uehara M, Suzuki K. Effects of dietary calcium supplementation on bone metabolism, kidney mineral concentrations, and kidney function in rats fed a high-phosphorus diet. J Nutr Sci Vitaminol. 2015;61(2):195–200.
Heaney RP, Recker RR. Effects of nitrogen, phosphorus, and caffeine on calcium balance in women. J Lab Clin Med. 1982;99(1):46–55.
Spencer H, Kramer L, Osis D, Norris C. Effect of phosphorus on the absorption of calcium and on the calcium balance in man. J Nutr. 1978;108(3):447–57.
Spencer H, Menczel J, Lewin I, Samachson J. Effect of high phosphorus intake on calcium and phosphorus metabolism in man. J Nutr. 1965;86:125–32.
Teegarden D, Lyle RM, McCabe GP, McCabe LD, Proulx WR, Michon K, et al. Dietary calcium, protein, and phosphorus are related to bone mineral density and content in young women. Am J Clin Nutr. 1998;68(3):749–54.
Sax L. The institute of medicine’s “dietary reference intake” for phosphorus: a critical perspective. J Am Coll Nutr. 2001;20(4):271–8.
Kemi VE, Karkkainen MU, Rita HJ, Laaksonen MM, Outila TA, Lamberg-Allardt CJ. Low calcium:phosphorus ratio in habitual diets affects serum parathyroid hormone concentration and calcium metabolism in healthy women with adequate calcium intake. Br J Nutr. 2010;103(4):561–8.
Carrigan A, Klinger A, Choquette SS, Luzuriaga-McPherson A, Bell EK, Darnell B, et al. Contribution of food additives to sodium and phosphorus content of diets rich in processed foods. J Ren Nutr. 2014;24(1):13–9. 9e1
Calvo MS, Uribarri J. Contributions to total phosphorus intake: all sources considered. Semin Dial. 2013;26(1):54–61.
McGartland C, Robson PJ, Murray L, Cran G, Savage MJ, Watkins D, et al. Carbonated soft drink consumption and bone mineral density in adolescence: the Northern Ireland young hearts project. J Bone Miner Res. 2003;18(9):1563–9.
Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2006;69(11):1945–53.
Moorthi RN, Moe SM. Recent advances in the noninvasive diagnosis of renal osteodystrophy. Kidney Int. 2013;84(5):886–94.
Kalantar-Zadeh K, Tortorici AR, Chen JL, Kamgar M, Lau WL, Moradi H, et al. Dietary restrictions in dialysis patients: is there anything left to eat? Semin Dial. 2015;28(2):159–68.
• Nelson SM, Sarabia SR, Christilaw E, Ward EC, Lynch SK, Adams MA, et al. Phosphate-containing prescription medications contribute to the daily phosphate intake in a third of hemodialysis patients. J Ren Nutr. 2017;27(2):91–6. This is an analysis of the phosphorus content of medications used by hemodialysis patients, showing that medications can contribute a meaningful amount of phosphorus to total intake for patients who are often advised to follow a phosphorus-restricted diet.
National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 Suppl 3):S1–201.
Sullivan C, Sayre SS, Leon JB, Machekano R, Love TE, Porter D, et al. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. J Am Med Assoc. 2009;301(6):629–35.
•• de Fornasari ML, Dos Santos Sens YA. Replacing phosphorus-containing food additives with foods without additives reduces phosphatemia in end-stage renal disease patients: a randomized clinical trial. J Ren Nutr. 2017;27(2):97–105. This is a 3-month randomized controlled trial of an educational intervention to decreased phosphate additive intake in hemodialysis patients that corroborates the work of Sullivan et al. (2009). Patients who received the intervention had significantly improved serum phosphate after three months, with no change in indicators of nutritional status.
Takeda E, Yamamoto H, Yamanaka-Okumura H, Taketani Y. Dietary phosphorus in bone health and quality of life. Nutr Rev. 2012;70(6):311–21.
Sehgal AR, Sullivan C, Leon JB, Bialostosky K. Public health approach to addressing hyperphosphatemia among dialysis patients. J Ren Nutr. 2008;18(3):256–61.
Karalis M. Food and Drug Administration petition on food labeling: an update from the American Dietetic Association and National Kidney Foundation. J Ren Nutr. 2007;17(6):423–4.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Kathleen Hill Gallant and Ranjani Moorthi report grants from the NIH (NIDDK K01 DK102864), during the conduct of the study.
Elizabeth Stremke and Colby Vorland declare no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Nutrition, Exercise and Lifestyle in Osteoporosis
Rights and permissions
About this article
Cite this article
Vorland, C.J., Stremke, E.R., Moorthi, R.N. et al. Effects of Excessive Dietary Phosphorus Intake on Bone Health. Curr Osteoporos Rep 15, 473–482 (2017). https://doi.org/10.1007/s11914-017-0398-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11914-017-0398-4